Company Search:
Advanced Search
Sponsored Links
Getein Biotech Inc Company Snapshot
Getein Biotech Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Getein Biotech Inc with three other companies in this sector in China: Beijing Leadman Biochemistry Co Ltd (2017 sales of 575.98 million Chinese Renmimbi [US$85.12 million] of which 100% was Biological products industry), Tellgen Corp (302.89 million Chinese Renmimbi [US$44.76 million] of which 94% was Reagent Income), and Guangdong Hybribio Biotech Co Ltd (479.09 million Chinese Renmimbi [US$70.80 million] of which 97% was Monitoring Instrument).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Getein Biotech Inc
  Stock Performance Chart for Getein Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 29.05
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 4.6%  
4 Weeks -10.3%   52 Weeks -16.7%  
Getein Biotech Inc Key Data:
  Ticker: 603387 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 488,582,766
(Year Ending Jan 2018).
Employees: 1,194
  Currency: Chinese Renmimbi Market Cap: 5,368,440,203
  Fiscal Yr Ends: December Shares Outstanding: 184,800,007
  Share Type: A Gu Closely Held Shares: 141,494,962
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.